Gland Pharma Limited IPO

Gland Pharma IPO
Gland Pharma IPO | Upcoming IPO | Latest IPO | New IPO | Upcoming IPO 2021 | New IPO 2021

Gland Pharma is one of the fastest growing generic injectables-focused companies, selling its products primarily under a business to business (B2B) model in over 60 countries including the United States, Europe, Canada, Australia, India and the Rest of the world.

Gland Pharma Company was established in Hyderabad, India in 1978 and has a professional management team and one of our Promoters, Shanghai Fosun Pharma, is a global pharmaceutical major.

Gland Pharma have a professional management team and one of the Promoters, Shanghai Fosun Pharma, is a global pharmaceutical major.

Gland Pharma has seven manufacturing facilities in India, comprising four finished formulations facilities with a total of 22 production lines and three API facilities.

As of March 31, 2020, it had manufacturing capacity for finished formulations of approximately 755 million units per annum.

 As of March 31, 2020, Gland Pharma along with its partners had 265 ANDA filings in the United States, of which 204 were approved and 61 were pending approval.

The 265 ANDA filings comprise 189 ANDA filings for sterile injectables, 50 for oncology and 26 for ophthalmics related products.

Gland Pharma IPO

Company Strengths

  1. The extensive product portfolio of complex injectables.
  2. Diversified B2B model with a targeted B2C model in India.
  3. Strong manufacturing capabilities.
  4. Robust financial track record.
  5. Experienced and qualified managerial team.

Company Financials

For the year/period ended (₹ in million)
Particulars31-Mar-2031-Mar-1931-Mar-18
Total Assets40,860.3935,235.4929,294.68
Total Revenue27,724.0821,297.6716,716.82
Profit After Tax7,728.584,518.563,210.51

Objects Of The Issue

The proceeds of the IPO will be used for the following purposes:

  • To finance the growing operating costs of our Company
  • To meet the financial requirements of the capital expenditure requirements
  • Meeting common cooperative goals
Gland Pharma IPO
Object Of The Issue

Gland Pharma IPO Details

IPO Open Date09 NOV 2020
IPO Close Date11 NOV 2020
Issue TypeBook Built Issue IPO
Issue Size₹ 6480 Cr
Offer for Sale34,863,635 Equity Share
Face Value₹1 Per Equity Share
IPO Price[1490] to [1500] per equity share
Market Lot10 Shares
Min Order Quantity10 Shares
Listing AtBSE, NSE

Gland Pharma IPO – Schedule

Bid/Offer Opens On09 NOV 2020
Bid/Offer Closes On11 NOV 2020
Finalisation of Basis of Allotment17 NOV 2020
Initiation of Refunds18 NOV 2020
Credit of Shares to Demat Acct19 NOV 2020
IPO Shares Listing Date20 NOV 2020

Gland Pharma IPO Lot Size and Price (Retail)

ApplicationLotsSharesAmount (Cut-off)
Minimum110₹15,000
Maximum13130₹1,95,000

Gland Pharma IPO: How To Apply

Promoters play a very important role in raising much-needed business revenue.

Gland Pharma IPO
HOw To Apply For IPO

Apply For Gland Pharma IPO Through ASBA

First, you should know what ASBA is. ASBA stands for Restricted Application Support. It is an application by the bank to apply for an IPO.

You apply with ASBA through the bank because initially, the bank covers the cost of purchasing the IPO. This amount is deducted from your account only after receiving IPO share shares in your Demat account.

All the major banks in the country are expanding the ASBA center. There are about 30 banks on the list, some of which are IDBI Bank Limited, Citi Bank, Punjab National Bank, etc.

The center may be expanded once they have been authorized to do so. These banks block the corresponding amount until the IPO allocation process is finalized.

Now, most of you are probably thinking about how to use the Gland Pharma IPO with ASBA. The process can be completed online or offline for your convenience.

Apart from this, you can also bid for an Gland Pharma IPO through your stockbroker’s online portal (such as Zerodha, Edelweiss, Motilal Oswal, etc.)

Company Contact Information

Gland Pharma Limited
Sy. No. 143 – 148, 150 and 151,
Near Gandi Maisamma ‘X’ Roads, D.P. Pally,Dundigal
Medchal-Malkajgiri District, Hyderabad

Phone: +91 40 3051 0999
Email: investors@glandpharma.com
Websitehttp://www.glandpharma.com

LIST OF UPCOMING IPOs